Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
Your view on TMO
Overview
What the company does, where it operates, and who runs it.
About Thermo Fisher Scientific Inc.
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Marc N. Casper
- Headquarters
- 168 Third Avenue, Waltham, MA, US
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Marc N. Casper
- Headquarters
- 168 Third Avenue, Waltham, MA, US
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.
The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products.
Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research.
It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD.
Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Thermo Fisher Scientific Inc. from FRC's valuation model, read against the market price. TMO last traded at $691.33, 36.4× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Thermo Fisher Scientific Inc.. Starting points for Thermo Fisher Scientific Inc.: P/E 36.4, EPS $19.14, beta 0.84 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Thermo Fisher Scientific Inc.. Thermo Fisher Scientific Inc. paid $1.84 per share over the last year — a 0.3% yield at the current $691.33 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Thermo Fisher Scientific Inc.. Trailing twelve-month EPS for Thermo Fisher Scientific Inc. stands at $19.14. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$707.10
average of 20 firms, last 12 months
Analyst Ratings
- Strong Buy0
- Buy10
- Hold3
- Sell0
- Strong Sell0
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $7.13 | $6.06 | $25.29 | $27.75 |
| Low estimate | $7.01 | $5.73 | $25.18 | $26.96 |
| High estimate | $7.26 | $6.23 | $25.43 | $29.24 |
| No. of analysts | 15 | 9 | 16 | 16 |
| Year-ago EPS | $6.57 | $5.44 | $17.74 | — |
| Growth | +8.5% | +11.4% | +42.6% | — |
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $12.84B | $11.74B | $48.00B | $50.57B |
| Low estimate | $12.69B | $11.63B | $47.83B | $50.32B |
| High estimate | $13.07B | $11.82B | $48.18B | $51.09B |
| No. of analysts | 13 | 8 | 20 | 19 |
| Year-ago revenue | $12.21B | $11.01B | $44.56B | — |
| Growth | +5.1% | +6.7% | +7.7% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0, MarketWatch; as of Nov 18, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Thermo Fisher Scientific Inc.. Thermo Fisher Scientific Inc. has reported as a listed company since 1980. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- AAgilent Technologies, Inc.Medical - Diagnostics & Research$48.8B
- BIOBio-Rad Laboratories, Inc.Medical - Devices$9.7B
- BRKRBruker CorporationMedical - Devices$9.3B
- DHRDanaher CorporationMedical - Diagnostics & Research$161.9B
- QGENQiagen N.V.Medical - Diagnostics & Research$10.3B
- RVTYRevvity, Inc.Medical - Diagnostics & Research$16.6B
More Medical - Diagnostics & Research companies
- SKHHYSonic Healthcare LimitedOTC$8.2B
- SLDXStella Diagnostics Inc.OTC$1M
- SPDESpeedus Corp.OTC$416
- SZLSFStageZero Life Sciences Ltd.OTC$61,766
- TDSGFTelo Genomics Corp.OTC$4M
- TELO.VTelo Genomics Corp.TSXV$4M
- THOXFBioPorto A/SOTC$74M
- TMO.NEThermo Fisher Scientific Inc.NEO
- TOMDFTodos Medical Ltd.OTC$14,081
- TTOOT2 Biosystems, Inc.OTC$11,218
- TWSTTwist Bioscience CorporationNASDAQ$6.9B
- VCYTVeracyte, Inc.NASDAQ$1.9B
ETFs holding Thermo Fisher Scientific Inc.
% of the fund
- VOOVanguard S&P 500 ETF$1.0T in assets0.39%
- VTIVanguard Total Stock Market ETF$689.2B in assets0.35%
- IVViShares Core SP 500 ETF$852.9B in assets0.40%
- SPYState Street SPDR S&P 500 ETF Trust$818.5B in assets0.40%
- QLTYGMO U.S. Quality ETF$5.4B in assets4.40%
- IYHiShares US Healthcare ETF$4.7B in assets3.72%
- FHLCFIDELITY MSCI HEALTH CARE INDEX ETF$4.0B in assets3.30%
- IXJiShares Global Healthcare ETF$4.6B in assets2.86%
Largest holders first, then the funds most concentrated in TMO.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Thermo Fisher Scientific Inc., and how their positions are changing. At a $256.15B market value, institutional positions materially move Thermo Fisher Scientific Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Thermo Fisher Scientific Inc. executives and directors. Shares of Thermo Fisher Scientific Inc. have traded between $385.46 and $610.97 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming Thermo Fisher Scientific Inc.. Thermo Fisher Scientific Inc. is a $256.15B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming Thermo Fisher Scientific Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Thermo Fisher Scientific Inc.. Coverage tracks Thermo Fisher Scientific Inc. within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.